RespireRx Pharmaceuticals Inc (RSPI)

[jerrydylan]

Exelisis (EXEL) just got $175 million up front from BMY for a cancer oriented phase 3 small molecule, and a pre-clinical molecule as well- though I believe it's joint deal -it's alot of cash and there are some quick milestones next year. The stock had already doubled off the bottom prior to the news and had been a falling knife all year. I think Cortex's deal will involve enough money to be worth it, worth doing for Cortex with some related OSA options-just a guess for now but the risk reward here looks very good-the money flow is fine, daily and weekly- but it's just droopy in the markets- A close over .80 is going to be the signal, it could happen fast.